Hypercholesterolemia Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: H3742E82D66EEN
Market Monitor Global

Abstracts

Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. Presence of low-density Lipoprotein Cholesterol (LDL-C) or bad cholesterol in the blood, may lead to cardiovascular diseases. Hypercholesterolemia is caused due to a combination of genetic and environmental factors. Environmental factors include excessive diet intake and obesity. In case of genetic factors, the number of copies of the gene determines the severity of the disease. People with the homozygous form (two copies of the gene) generally suffer from severe cardiovascular diseases during childhood, while those with the heterozygous form (with a single copy of the gene) suffer from heart diseases in their 30s or 40s.

This report contains market size and forecasts of Hypercholesterolemia Treatment in Global, including the following market information:

Global Hypercholesterolemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hypercholesterolemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

AEM-2802 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hypercholesterolemia Treatment include CymaBay Therapeutics Inc, Daewoong Co Ltd, Gemphire Therapeutics Inc, LipimetiX Development Inc, Regeneron Pharmaceuticals Inc, RegenxBio Inc and The Medicines Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypercholesterolemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hypercholesterolemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hypercholesterolemia Treatment Market Segment Percentages, by Type, 2021 (%)

• AEM-2802
• AEM-2814
• Alirocumab
• Evinacumab
• Others

Global Hypercholesterolemia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hypercholesterolemia Treatment Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• Others

Global Hypercholesterolemia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hypercholesterolemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hypercholesterolemia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hypercholesterolemia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• CymaBay Therapeutics Inc
• Daewoong Co Ltd
• Gemphire Therapeutics Inc
• LipimetiX Development Inc
• Regeneron Pharmaceuticals Inc
• RegenxBio Inc
• The Medicines Company

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hypercholesterolemia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hypercholesterolemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HYPERCHOLESTEROLEMIA TREATMENT OVERALL MARKET SIZE

2.1 Global Hypercholesterolemia Treatment Market Size: 2021 VS 2028
2.2 Global Hypercholesterolemia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hypercholesterolemia Treatment Players in Global Market
3.2 Top Global Hypercholesterolemia Treatment Companies Ranked by Revenue
3.3 Global Hypercholesterolemia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hypercholesterolemia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hypercholesterolemia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hypercholesterolemia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hypercholesterolemia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hypercholesterolemia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hypercholesterolemia Treatment Market Size Markets, 2021 & 2028
  4.1.2 AEM-2802
  4.1.3 AEM-2814
  4.1.4 Alirocumab
  4.1.5 Evinacumab
  4.1.6 Others
4.2 By Type - Global Hypercholesterolemia Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hypercholesterolemia Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Hypercholesterolemia Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Hypercholesterolemia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hypercholesterolemia Treatment Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global Hypercholesterolemia Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hypercholesterolemia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Hypercholesterolemia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Hypercholesterolemia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hypercholesterolemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hypercholesterolemia Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hypercholesterolemia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Hypercholesterolemia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Hypercholesterolemia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hypercholesterolemia Treatment Revenue, 2017-2028
  6.3.2 US Hypercholesterolemia Treatment Market Size, 2017-2028
  6.3.3 Canada Hypercholesterolemia Treatment Market Size, 2017-2028
  6.3.4 Mexico Hypercholesterolemia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hypercholesterolemia Treatment Revenue, 2017-2028
  6.4.2 Germany Hypercholesterolemia Treatment Market Size, 2017-2028
  6.4.3 France Hypercholesterolemia Treatment Market Size, 2017-2028
  6.4.4 U.K. Hypercholesterolemia Treatment Market Size, 2017-2028
  6.4.5 Italy Hypercholesterolemia Treatment Market Size, 2017-2028
  6.4.6 Russia Hypercholesterolemia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Hypercholesterolemia Treatment Market Size, 2017-2028
  6.4.8 Benelux Hypercholesterolemia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hypercholesterolemia Treatment Revenue, 2017-2028
  6.5.2 China Hypercholesterolemia Treatment Market Size, 2017-2028
  6.5.3 Japan Hypercholesterolemia Treatment Market Size, 2017-2028
  6.5.4 South Korea Hypercholesterolemia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Hypercholesterolemia Treatment Market Size, 2017-2028
  6.5.6 India Hypercholesterolemia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hypercholesterolemia Treatment Revenue, 2017-2028
  6.6.2 Brazil Hypercholesterolemia Treatment Market Size, 2017-2028
  6.6.3 Argentina Hypercholesterolemia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hypercholesterolemia Treatment Revenue, 2017-2028
  6.7.2 Turkey Hypercholesterolemia Treatment Market Size, 2017-2028
  6.7.3 Israel Hypercholesterolemia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Hypercholesterolemia Treatment Market Size, 2017-2028
  6.7.5 UAE Hypercholesterolemia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 CymaBay Therapeutics Inc
  7.1.1 CymaBay Therapeutics Inc Corporate Summary
  7.1.2 CymaBay Therapeutics Inc Business Overview
  7.1.3 CymaBay Therapeutics Inc Hypercholesterolemia Treatment Major Product Offerings
  7.1.4 CymaBay Therapeutics Inc Hypercholesterolemia Treatment Revenue in Global Market (2017-2022)
  7.1.5 CymaBay Therapeutics Inc Key News
7.2 Daewoong Co Ltd
  7.2.1 Daewoong Co Ltd Corporate Summary
  7.2.2 Daewoong Co Ltd Business Overview
  7.2.3 Daewoong Co Ltd Hypercholesterolemia Treatment Major Product Offerings
  7.2.4 Daewoong Co Ltd Hypercholesterolemia Treatment Revenue in Global Market (2017-2022)
  7.2.5 Daewoong Co Ltd Key News
7.3 Gemphire Therapeutics Inc
  7.3.1 Gemphire Therapeutics Inc Corporate Summary
  7.3.2 Gemphire Therapeutics Inc Business Overview
  7.3.3 Gemphire Therapeutics Inc Hypercholesterolemia Treatment Major Product Offerings
  7.3.4 Gemphire Therapeutics Inc Hypercholesterolemia Treatment Revenue in Global Market (2017-2022)
  7.3.5 Gemphire Therapeutics Inc Key News
7.4 LipimetiX Development Inc
  7.4.1 LipimetiX Development Inc Corporate Summary
  7.4.2 LipimetiX Development Inc Business Overview
  7.4.3 LipimetiX Development Inc Hypercholesterolemia Treatment Major Product Offerings
  7.4.4 LipimetiX Development Inc Hypercholesterolemia Treatment Revenue in Global Market (2017-2022)
  7.4.5 LipimetiX Development Inc Key News
7.5 Regeneron Pharmaceuticals Inc
  7.5.1 Regeneron Pharmaceuticals Inc Corporate Summary
  7.5.2 Regeneron Pharmaceuticals Inc Business Overview
  7.5.3 Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Major Product Offerings
  7.5.4 Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Revenue in Global Market (2017-2022)
  7.5.5 Regeneron Pharmaceuticals Inc Key News
7.6 RegenxBio Inc
  7.6.1 RegenxBio Inc Corporate Summary
  7.6.2 RegenxBio Inc Business Overview
  7.6.3 RegenxBio Inc Hypercholesterolemia Treatment Major Product Offerings
  7.6.4 RegenxBio Inc Hypercholesterolemia Treatment Revenue in Global Market (2017-2022)
  7.6.5 RegenxBio Inc Key News
7.7 The Medicines Company
  7.7.1 The Medicines Company Corporate Summary
  7.7.2 The Medicines Company Business Overview
  7.7.3 The Medicines Company Hypercholesterolemia Treatment Major Product Offerings
  7.7.4 The Medicines Company Hypercholesterolemia Treatment Revenue in Global Market (2017-2022)
  7.7.5 The Medicines Company Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hypercholesterolemia Treatment Market Opportunities & Trends in Global Market
Table 2. Hypercholesterolemia Treatment Market Drivers in Global Market
Table 3. Hypercholesterolemia Treatment Market Restraints in Global Market
Table 4. Key Players of Hypercholesterolemia Treatment in Global Market
Table 5. Top Hypercholesterolemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hypercholesterolemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hypercholesterolemia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hypercholesterolemia Treatment Product Type
Table 9. List of Global Tier 1 Hypercholesterolemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hypercholesterolemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hypercholesterolemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hypercholesterolemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hypercholesterolemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hypercholesterolemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hypercholesterolemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hypercholesterolemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hypercholesterolemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hypercholesterolemia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hypercholesterolemia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hypercholesterolemia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hypercholesterolemia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hypercholesterolemia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hypercholesterolemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hypercholesterolemia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. CymaBay Therapeutics Inc Corporate Summary
Table 31. CymaBay Therapeutics Inc Hypercholesterolemia Treatment Product Offerings
Table 32. CymaBay Therapeutics Inc Hypercholesterolemia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Daewoong Co Ltd Corporate Summary
Table 34. Daewoong Co Ltd Hypercholesterolemia Treatment Product Offerings
Table 35. Daewoong Co Ltd Hypercholesterolemia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Gemphire Therapeutics Inc Corporate Summary
Table 37. Gemphire Therapeutics Inc Hypercholesterolemia Treatment Product Offerings
Table 38. Gemphire Therapeutics Inc Hypercholesterolemia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. LipimetiX Development Inc Corporate Summary
Table 40. LipimetiX Development Inc Hypercholesterolemia Treatment Product Offerings
Table 41. LipimetiX Development Inc Hypercholesterolemia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Regeneron Pharmaceuticals Inc Corporate Summary
Table 43. Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Product Offerings
Table 44. Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Revenue (US$, Mn), (2017-2022)
Table 45. RegenxBio Inc Corporate Summary
Table 46. RegenxBio Inc Hypercholesterolemia Treatment Product Offerings
Table 47. RegenxBio Inc Hypercholesterolemia Treatment Revenue (US$, Mn), (2017-2022)
Table 48. The Medicines Company Corporate Summary
Table 49. The Medicines Company Hypercholesterolemia Treatment Product Offerings
Table 50. The Medicines Company Hypercholesterolemia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hypercholesterolemia Treatment Segment by Type in 2021
Figure 2. Hypercholesterolemia Treatment Segment by Application in 2021
Figure 3. Global Hypercholesterolemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hypercholesterolemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hypercholesterolemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hypercholesterolemia Treatment Revenue in 2021
Figure 8. By Type - Global Hypercholesterolemia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hypercholesterolemia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hypercholesterolemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hypercholesterolemia Treatment Revenue Market Share, 2017-2028
Figure 12. US Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hypercholesterolemia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hypercholesterolemia Treatment Revenue Market Share, 2017-2028
Figure 24. China Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hypercholesterolemia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hypercholesterolemia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hypercholesterolemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. CymaBay Therapeutics Inc Hypercholesterolemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Daewoong Co Ltd Hypercholesterolemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gemphire Therapeutics Inc Hypercholesterolemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. LipimetiX Development Inc Hypercholesterolemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. RegenxBio Inc Hypercholesterolemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. The Medicines Company Hypercholesterolemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)